Publicacions en què col·labora amb Elisa Garcia Vazquez (13)

2024

  1. Anticipating the side effects of benznidazole: HLA-B*35 and patch test

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 430-434

2023

  1. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  2. Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole

    Revista da Sociedade Brasileira de Medicina Tropical, Vol. 56

2022

  1. Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”

    Journal of Infection, Vol. 84, Núm. 3, pp. 343-350

  2. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

    JAMA Network Open, Vol. 5, Núm. 1

  3. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

    PLoS ONE, Vol. 17, Núm. 2 February

2020

  1. Pregnancy and Chagas disease: Benznidazole's impact on pregnancy and newborns: A report of four cases

    American Journal of Tropical Medicine and Hygiene, Vol. 102, Núm. 5, pp. 1075-1077

  2. Usefulness of the epidemiological survey and RT–PCR test in pre-surgical patients for assessing the risk of COVID-19

    Journal of Hospital Infection

2018

  1. Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (Carbapenems included): Predictive and prognostic factors. A prospective study (2016-2017)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 123-130

2013

  1. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 203-213

2012

  1. Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality

    Medicina Clinica, Vol. 138, Núm. 15, pp. 650-655

2011

  1. Bacteriemias por Escherichia coli productor de betalactamasas de espectro extendido (BLEE): Significación clínica y perspectivas actuales

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 2, pp. 57-66

2010

  1. Acinetobacter baumanii multirresistente: Situación clínica actual y nuevas perspectivas

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 1, pp. 12-19